A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through Menopause
Clinical trial NCT06206421 · COMPLETED
Trial details
- NCT number
- NCT06206421
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-22
- Primary completion
- 2026-03-19
- Enrollment
- 277
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.